A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of CombinationTreatment with MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients with Recurrent / MetastaticHuman Papilloma Virus Associated Head and Neck Squamous

Project: Research project

Project Details

Description

A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of Combination Treatment with MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients with Recurrent / Metastatic Human Papilloma Virus Associated Head and Neck Squamous
StatusActive
Effective start/end date5/16/185/30/23

Funding

  • AstraZeneca

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.